Steeper Group

Our vision is to be the world’s first choice for dynamic and progressive prosthetic, orthotic and assistive technology products and services

With a history stretching back almost 100 years, we are a pioneering name in prosthetics, orthotics and assistive technology, bringing together innovative products, craft, and continuously committed clinical services to do one thing: create fundamental, positive turning points that enhance and empower lives.

For more information on Steeper Group, please visit our website. 

12:08 Tuesday 23rd January

Was the moment when Stuart became part of the British Talent Squad.
Read Stuart's story

10:07 Friday 12th August

Was the moment Charlotte regained a piece of her old reflection thanks to the Steeper Silicone Clinic.
Read Charlotte's story

15:15 Thursday 22nd January

Was the first time four-year-old Alfie could walk home from school without leg pain.
Read Alfie's story

Owners of Steeper Group

February 2017 saw changes to the ownership of Steeper Group. Two members of the executive board of directors, Paul Steeper, CEO and John Midgley, Finance Director, acquired Steeper Group from UK mid-market private equity firm, Dunedin. For many years, Steeper had been owned by private equity firms, and by Dunedin since 2005. This particular investment and support were vital in enabling the company to grow.  However, as part of the agreement, the company’s bebionic area of the business transferred ownership to German prosthetics company, Ottobock.

Almost 100 years ago, Steeper Group was founded by Paul Steeper’s late grandfather, Hugh. The company initially set out to provide prosthetic limbs to veterans of the Great War, and since then has expanded across prosthetics, orthotics and assistive technology – with a focus on creating significant turning points in individuals’ lives through exceptional clinical services and award-winning products.

Paul Steeper and John Midgley’s combined 40 years’ experience at the company will ensure a smooth continuation of the business. At the time of the announcement, John Midgley said, “For many years, Steeper has been owned by private equity firms, which has enabled the company to grow to its current position in the market. We are delighted to be moving forward on a new journey from this strong base. Both Paul and I have been long-standing members of the executive board of directors, and are confident and excited about what the future holds.”

Paul Steeper added, “We have enjoyed our time with Dunedin and greatly appreciate the support we have received. We are now looking forward to the future as we seek to further strengthen our existing positive relationships with customers, our distributors and our suppliers, and continuing to provide the best products and services to the industry”.

Nicholas Hoare from Dunedin said of the investment, “We invested in Steeper in 2005 to support its growth plans helping it to break into new markets including the US and launching new products such as the bebionic hand. The sale to Ottobock is an excellent fit and we are confident that the business will continue to deliver on its growth ambitions.”

KPMG (Christian Mayo and Ben Taylor) advised the shareholders of Steeper on the deal. Christian Mayo, partner and head of corporate finance at KPMG in Yorkshire, said: “When it comes to the wider industry, MedTech is an exciting, high-growth sector that is continually evolving – particularly in our region. As a result, we’re seeing a great deal of interest from both the investment community and trade buyers for this type of business and it’s an area we expect to see more activity in throughout the year ahead.”

For further information on Steeper Group, please contact